UNSPSC 51162701: Acetylcysteine

This classification denotes a mucolytic agent and antioxidant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) WYQ7N0BPYC. European Medicines Agency schedules Acetylcysteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05229MIG. Acetylcysteine generally arises in the molecular formula C5H9NO3S. The term ACETYLCYSTEINE is an International Nomenclature of Cosmetic Ingredients designation.

UNSPSC 51162701 Acetylcysteine is a Commodity code that covers pharmaceutical products used in clinical settings, though the recent state and local solicitation activity under this code shows substantial breadth beyond acetylcysteine itself. The Washington State Department of Corrections is procuring parenteral products, services, and equipment — including parenteral nutrition solutions (TPN and PPN), intravenous solutions, and other parenteral products including controlled substances — for eight correctional facilities across the state. This work involves not just product supply but also documentation of experience in IV solution preparation, patient lab-result monitoring, and the ability to adjust nutritional formulations to individual patient needs. A second opportunity posted by Seminole County, Florida addresses naloxone and drug deactivation systems for community health initiatives, though the connection to this acetylcysteine commodity code appears tangential. State and local buyers under this code include state corrections departments and county public health authorities. The issuing bodies apply competitive set-asides and preferences: Washington DOC encourages participation from small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), with aspirational diverse-business goals and subcontractor inclusion requirements, while Seminole County applies standard compliance requirements including drug-free workplace certification and E-Verify.

Recent activity centers on Washington and Florida. The Washington State Department of Corrections' RFQ (RFQQK13020) for parenteral products closes October 7, 2026, with a pre-bid conference on September 23, 2026 and questions due September 22, 2026; DOC anticipates awarding up to three contractors per geographic region (West, Central, East) with an initial contract term from November 26, 2026 through June 30, 2030, fixed pricing for the first two years, and 24-hour delivery requirements for customized nutrition bags and 8-hour delivery windows for other parenteral products. The Seminole County IFB (IFB60459723LAS) for naloxone and drug deactivation systems required quarterly deliveries to Seminole County Community Health Building with a two-year initial term and one-year renewal option, though the posted due date (July 26, 2023) is dated and likely represents a historical reference. Contractors must carry substantial insurance (Washington DOC requires $1–2 million commercial general liability and $2 million cyber liability; Seminole County requires workers' compensation, commercial general liability, and professional liability) and meet state business licensure and background-clearance standards.